A rich source of innovation for the Ceva Group.
If there is one field in which Ceva Santé Animale has demonstrated the full extent of its innovation capacities, it is that of companion animals.
CAT AND DOG BEHAVIOUR
Through several major innovations, Ceva has opened up the possibility for vets to address behavioural disorders in cats and dogs, an area about which little was known until now and the subject of few clinical studies.
- 1996: Beginning of a new therapeutic approach: launch of FELIWAY® to treat behavioural disorders in cats
- 2015 : Launch of FELIWAY® MultiCat to help decrease tension and conflict in multicat homes
Although it benefits from little media attention (compared with flea treatments, for example!), cardiology is a science in which progress is being achieved, extending the lifespan of dogs in parallel with that of their owners.
LOCOMOTION AND ANALGESIA
With animal welfare in mind, Ceva offers a range of medicines to relieve pain in companion animals.
Antibiotic treatment is one of Ceva’s areas of expertise, with the company offering a very wide range of antibiotic molecules.
OTHER THERAPEUTIC FIELDS
Another innovation comes in the field of reproduction: GALASTOP®, a prolactin inhibitor used to treat lactation in pseudopregnancy (“false pregnancies”) in dogs.
Mention should also be made of DIARSANYL® (Montmorillonite), an adjunct treatment for idiopathic diarrhoea in cats and dogs.